Navigation Links
Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial

Provides Update to Timeline for Second Pivotal Phase 3 Trial CL-05

CHICAGO, July 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , today announced the confirmation of supplemental efficacy data from Trial CL-06, the first of two pivotal Phase 3 clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day antibiotic, for the treatment of community acquired pneumonia (CAP). The Company also provided an update to the projected timeline for announcement of top-line data from the second CAP study, Trial CL-05.

The Company is hosting a conference call and live webcast at 10:00 am (EDT) today, July 2, 2007 to discuss the available data from Trial CL-06. On the call will be members of the Advanced Life Sciences management team along with Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases.

Statistical Considerations For Non-Inferiority

For statistical analysis pursuant to the Company's protocol and consistent with levels established in precedent FDA antibiotic drug approvals, non- inferiority at a 95% confidence interval is established when:

    -- The delta value is 10% or less on the lower bound and includes zero on

       the upper bound when the higher clinical cure rate of either

       cethromycin or Biaxin(R) is 90% or greater.

    -- The delta value is 15% or less on the lower bound and includes zero on

       the upper bound when the higher clinical cure rate of either

       cethromycin or Biaxin(R) is between 80% and 90%.

In addition, a p-value greater than 0.05 indicates that there is not a statistically significant difference between the study drug and comparator and supports non-inferiority.

The Company previously announced cethromycin's achievement of non-inferiority in the per protocol clinical cure rate compared to Biaxin(R) (clarithromycin) in CAP (cethro
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
5. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
6. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
9. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
10. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
11. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
Post Your Comments:
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "North ... & Graft), by Application (Surgical Wound, & Ulcer), ... Forecast to 2019" report to their offering. ... wound care market is estimated to grow at ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... Sept. 21 The Association of Medical Media (AMM) ... highest-scoring medical journal advertisements Thursday, September 16, 2010.   ... annual study developed by AMM, researches physician attitudes toward ... 21 specialties from the 86 most widely-advertised products in ...
... More than one in three diabetes patients skip doses ... they have done so on average three times in the ... reality this number could be as high as six doses*, ... Insulin Therapy (GAPP™) survey, released today by Novo Nordisk. ...
Cached Medicine Technology:AMM Names 2010 Doctors' Choice Awards Winners 2AMM Names 2010 Doctors' Choice Awards Winners 3New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Dr. David Benvenuti, ... has just posted a new article to his ... As Dr Benvenuti explained in the fascinating blog, ... plugs in their earlobes. , Known as “gauging,” the technique ... hole, which Dr. Benvenuti said will eventually stretch the holes ...
(Date:5/23/2015)... A live auction will be held to sell ... and other medical facilities around the United States. Various ... surgery, anesthesia, exam and much more. , The live ... 28 starting at 9:00am CDT each day. The equipment is ... Melrose Park, IL 60160. Anyone can participate in the ...
(Date:5/22/2015)... 2015 Pioneer Millworks, the largest reclaimed ... of designing with reclaimed wood, introducing their latest reclaimed ... California. Their newest offerings, Vat 35, Reclaimed Teak ... color to America's largest design event. , “Designers, architects, ... show, anxious to see and feel the variety of ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... shows that the prevalence of hay fever and eczema in ... risen sharply.// ,In the research that has been ... the University of Edinburgh have said that the rates of ... years of steady rise but at the same time allergic ...
... of developing lymphoma and leukemia. The autoimmune, inflammatory disease ... the risk of cancer. //Researchers speculate that antirheumatic drugs ... a type of biologic DMARD may play a role ... attaching to and impeding chemical messengers behind inflammation, have ...
... Researchers say that in Asian children must be given Vitamin ... order to avert the reappearance of deficiency symptoms. //Researchers examined ... and have published their findings in the latest issue of ... can cause rickets, poor tooth formation, convulsions, general ill health, ...
... who carried donor cards no longer have the last say ... new laws will come into force that will make the ... carry a donor card, their relatives can prevent doctors from ... reported to do so. ,The new laws have come into ...
... in traumatic head injuries among Canadians under age 19 ... released on Wednesday.// ,When the Canadian Institute for ... injuries from 1994 to 2004 it found that overall, ... with children and youth showing the largest drop. ...
... are genetically more suited to being vegetarians than meat-eaters is ... by more then 300 leading scientists from New Zealand and ... a cure for cancer is also under discussion at the ... of the conference says the finding that a human is ...
Cached Medicine News:Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:RA Drugs Not Implicated In Cancer 2Health News:Asian Children Need More Vitamin D Supplements 2Health News:Families of the Dead no Longer Have the Last Say 2Health News:Families of the Dead no Longer Have the Last Say 3
... amplifier in the world. ,XLTEK EEG ... for accurate data acquisition with 500 Hz ... the highest signal-to-noise ratios available and fast ... All of this is for one purpose ...
... The cold-light illumination can be used ... the Head-worn Loupe KF Titanium and the ... the almost coaxial illumination, even in unfavorable ... The flexible, lightweight liquid light guide ensures ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
... from Bausch & Lomb provides fingertip control ... one handed delivery of the IOL directly ... bag is assured by planar delivery. Leading ... into the capsular bag without sweeping motion. ...
Medicine Products: